Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CUTA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EBPL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFNAR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ST8SIA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHID1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GOLGB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YIF1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM261 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALG5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ETF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FDFT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR1908 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNFSF12-TNFSF13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
RDH13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSME1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARPC5L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYNLL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDFIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LPCAT4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDKN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on